Source: VAERS.HHS.GOV
VAERS accepts reports of adverse events and reactions that occur following vaccination. Healthcare providers, vaccine manufacturers, and the public can submit reports to the system. While very important in monitoring vaccine safety, VAERS reports alone cannot be used to determine if a vaccine caused or contributed to an adverse event or illness. The reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. In large part, reports to VAERS are voluntary, which means they are subject to biases. This creates specific limitations on how the data can be used scientifically. Data from VAERS reports should always be interpreted with these limitations in mind.
The strengths of VAERS are that it is national in scope and can quickly provide an early warning of a safety problem with a vaccine. As part of CDC and FDA’s multi-system approach to post-licensure vaccine safety monitoring, VAERS is designed to rapidly detect unusual or unexpected patterns of adverse events, also known as “safety signals.” If a safety signal is found in VAERS, further studies can be done in safety systems such as the CDC’s Vaccine Safety Datalink (VSD) or the Clinical Immunization Safety Assessment (CISA) project. These systems do not have the same scientific limitations as VAERS, and can better assess health risks and possible connections between adverse events and a vaccine.
Key considerations and limitations of VAERS data:
VAERS data available to the public include only the initial report data to VAERS. Updated data which contains data from medical records and corrections reported during follow up are used by the government for analysis. However, for numerous reasons including data consistency, these amended data are not available to the public.
very tender; limited range of motion in neck due to pain.; 30Apr2021 lymph node extremely painful to touch; lymph node the size of a golf ball within 6hrs after injection; This is a spontaneous report from a contactable other health care professional (patient). A 34-year-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: Ew0161), via an unspecified route of administration, administered in left arm on 29Apr2021 (at the age of 34 years) as dose 2, single for COVID-19 immunization. The patient's medical history included allergy to pears. The patient's concomitant medications were not reported. The patient did not receive other vaccine in four weeks. The patient did not receive other medications in two weeks. The patient did not have COVID prior vaccination. The patient did not get COVID tested post vaccination. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ER8730), via an unspecified route of administration, administered in left arm on 06Apr2021 10:00 (at the age of 34 years) as dose 1, single for COVID-19 immunization and noticed swollen lymph node after 1 week, was smaller but still noticeable. On 29Apr2021 lymph node the size of a golf ball within 6hrs after injection on 30Apr2021 lymph node extremely painful to touch and limited range of motion in neck due to pain on an unspecified date patient experienced very tender. It was reported that Swollen lymph node above collarbone on same side as injection after both doses. Very swollen and very tender after 2nd dose. Received 2nd dose 29Apr2021, lymph node the size of a golf ball within 6hrs after injection. 30Apr2021 lymph node extremely painful to touch, limited range of motion in neck due to pain. The outcome of the events was not recovered. No follow-up attempts are possible. No further information is expected.
Open in Wayback Machine
(If this is a foreign report without a description you will be able to read the description in the Wayback Machine on Medalerts if the report became public for the first time before November 18, 2022.)
| Name | Dose # | Type | Manufacturer | Lot | Route | Site |
|---|---|---|---|---|---|---|
| COVID19 (COVID19 (PFIZER-BIONTECH)) | 2 | COVID19 | PFIZER\BIONTECH | EW0161 | LA |
| RECVDATE: | 11-18-2021 | RPT_DATE: |
| CAGE_YR: | |
| CAGE_MO: | |
| DIED: | U |
| DATEDIED: | |
| L_THREAT: | U |
| ER_VISIT: | |
| HOSPITAL: | U |
| HOSPDAYS: | |
| X_STAY: | U |
| DISABLE: | U |
| RECOVD: | N |
| LAB_DATA: | |
| V_ADMINBY: | PHM |
| OTHER_MEDS: | |
| CUR_ILL: | |
| HISTORY: | Medical History/Concurrent Conditions: Food allergy |
| PRIOR_VAX: | |
| SPLTTYPE: | USPFIZER INC2021486668 |
| FORM_VERS: | |
| TODAYS_DATE: | 11-16-2021 |
| BIRTH_DEFECT: | U |
| OFC_VISIT: | U |
| ER_ED_VISIT: | U |
| ALLERGIES: | |
| V_FUNDBY: |
Questions? Comments? Bugs?
[email protected]
Due to the high volume of inquiries, please be patient with response times.
AND PLEASE read the FAQ first.
OpenVAERS is a private organization that posts publicly available CDC/FDA data of injuries reported post-vaccination. Reports are not proof of causality.